IN172160B - - Google Patents

Info

Publication number
IN172160B
IN172160B IN296/MAS/91A IN296MA1991A IN172160B IN 172160 B IN172160 B IN 172160B IN 296MA1991 A IN296MA1991 A IN 296MA1991A IN 172160 B IN172160 B IN 172160B
Authority
IN
India
Application number
IN296/MAS/91A
Other languages
English (en)
Inventor
Salimbeni Aldo
Manghishi Elso
Caliari Saturnino
Fici Francesco
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of IN172160B publication Critical patent/IN172160B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IN296/MAS/91A 1990-04-27 1991-04-15 IN172160B (US06262066-20010717-C00315.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20160A IT1240686B (it) 1990-04-27 1990-04-27 Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
PCT/EP1991/000742 WO1991017153A1 (en) 1990-04-27 1991-04-18 1,5-benzothiazepinone derivatives, their preparations and pharmaceutical use

Publications (1)

Publication Number Publication Date
IN172160B true IN172160B (US06262066-20010717-C00315.png) 1993-04-17

Family

ID=11164306

Family Applications (1)

Application Number Title Priority Date Filing Date
IN296/MAS/91A IN172160B (US06262066-20010717-C00315.png) 1990-04-27 1991-04-15

Country Status (20)

Country Link
US (1) US5571807A (US06262066-20010717-C00315.png)
EP (1) EP0526495A1 (US06262066-20010717-C00315.png)
JP (1) JPH05506654A (US06262066-20010717-C00315.png)
CN (1) CN1056101A (US06262066-20010717-C00315.png)
AU (1) AU645317B2 (US06262066-20010717-C00315.png)
BG (1) BG97014A (US06262066-20010717-C00315.png)
BR (1) BR9106372A (US06262066-20010717-C00315.png)
CA (1) CA2081204A1 (US06262066-20010717-C00315.png)
CS (1) CS120991A2 (US06262066-20010717-C00315.png)
FI (1) FI924756A (US06262066-20010717-C00315.png)
HU (1) HU9203326D0 (US06262066-20010717-C00315.png)
IE (1) IE71033B1 (US06262066-20010717-C00315.png)
IL (1) IL97859A0 (US06262066-20010717-C00315.png)
IN (1) IN172160B (US06262066-20010717-C00315.png)
IT (1) IT1240686B (US06262066-20010717-C00315.png)
MA (1) MA22143A1 (US06262066-20010717-C00315.png)
PT (1) PT97508A (US06262066-20010717-C00315.png)
RO (1) RO111269B1 (US06262066-20010717-C00315.png)
WO (1) WO1991017153A1 (US06262066-20010717-C00315.png)
ZA (1) ZA913171B (US06262066-20010717-C00315.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118292T3 (es) * 1994-09-16 1998-09-16 Orion Corp Fermion Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.
US5559229A (en) * 1995-06-01 1996-09-24 Acic (Canada) Inc. Method for the manufacture of benzothiazepine
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
WO2006079077A2 (en) * 2005-01-20 2006-07-27 Acadia Pharmaceuticals Inc. Use of diltiazem or analogs thereof as modulators of ghrelin receptor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
DE3771143D1 (de) * 1986-08-20 1991-08-08 Mcneilab Inc Benzothiazepin-vasodilatoren mit aralkylsubstitution.
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
ES2069003T3 (es) * 1989-04-28 1995-05-01 Tanabe Seiyaku Co Procedimiento para preparar derivados de 1,5-benzotiazepina.
JPH085869B2 (ja) * 1990-03-08 1996-01-24 田辺製薬株式会社 1,5−ベンゾチアゼピン誘導体の製法

Also Published As

Publication number Publication date
IT9020160A0 (it) 1990-04-27
CN1056101A (zh) 1991-11-13
WO1991017153A1 (en) 1991-11-14
MA22143A1 (fr) 1991-12-31
BR9106372A (pt) 1993-04-27
RO111269B1 (ro) 1996-08-30
AU7695491A (en) 1991-11-27
IT9020160A1 (it) 1991-10-27
ZA913171B (en) 1992-02-26
FI924756A0 (fi) 1992-10-20
CA2081204A1 (en) 1991-10-28
EP0526495A1 (en) 1993-02-10
CS120991A2 (en) 1991-12-17
IT1240686B (it) 1993-12-17
BG97014A (bg) 1993-12-24
PT97508A (pt) 1992-01-31
JPH05506654A (ja) 1993-09-30
IE911411A1 (en) 1991-11-06
US5571807A (en) 1996-11-05
IL97859A0 (en) 1992-06-21
HU9203326D0 (en) 1993-01-28
IE71033B1 (en) 1997-01-15
FI924756A (fi) 1992-10-20
AU645317B2 (en) 1994-01-13

Similar Documents

Publication Publication Date Title
FR2668597B1 (US06262066-20010717-C00315.png)
EP0484506A4 (US06262066-20010717-C00315.png)
FR2660147B1 (US06262066-20010717-C00315.png)
IN171897B (US06262066-20010717-C00315.png)
FR2660741B1 (US06262066-20010717-C00315.png)
FR2670452B1 (US06262066-20010717-C00315.png)
IN172038B (US06262066-20010717-C00315.png)
FR2660251B1 (US06262066-20010717-C00315.png)
FR2657438B1 (US06262066-20010717-C00315.png)
FR2664850B1 (US06262066-20010717-C00315.png)
FR2659785B1 (US06262066-20010717-C00315.png)
FR2669783B1 (US06262066-20010717-C00315.png)
FR2667380B1 (US06262066-20010717-C00315.png)
FR2670534B1 (US06262066-20010717-C00315.png)
FR2657181B1 (US06262066-20010717-C00315.png)
FR2669985B1 (US06262066-20010717-C00315.png)
IN172160B (US06262066-20010717-C00315.png)
FR2657278B2 (US06262066-20010717-C00315.png)
IN172899B (US06262066-20010717-C00315.png)
IN175543B (US06262066-20010717-C00315.png)
IN174746B (US06262066-20010717-C00315.png)
IN171577B (US06262066-20010717-C00315.png)
IN172845B (US06262066-20010717-C00315.png)
IN174920B (US06262066-20010717-C00315.png)
IN173130B (US06262066-20010717-C00315.png)